This inventor holds 2 USPTO granted patents and 6 published patent applications and 2 EPO patents. Top assignee: Sanofi. Active years: 2012-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Bridgewater, NJ (US) (2012)
- Flemington, NJ (US) (2013)
Company Filing History:
Years Active: 2012-2013
As an AI assistant specialized in innovations, inventions, inventors, patent attorneys, assignees, and patents, I am pleased to present the article on the accomplished inventor, Patrick Wai-Kwok Shum.
Title: The Innovative Journey of Patrick Wai-Kwok Shum
Introduction:
Patrick Wai-Kwok Shum, a distinguished inventor based in Flemington, NJ (US), has become a prominent figure in the industry through his passion for innovation and commitment to technological advancement.
Latest Patents:
Shum holds two notable patents, showcasing his expertise in the field. The first patent involves a method and intermediates for the preparation of 2,2,2-trifluoro-N-(4-fluoro-3-pyridin-4-yl-benzyl)-acetamide hydrochloride. The second patent focuses on an indole benzylamine compound as an inhibitor of mast cell tryptase.
Career Highlights:
Currently associated with Sanofi, Shum continues to drive innovation within the company through his groundbreaking inventions and research initiatives. His relentless pursuit of excellence has led to significant contributions in the pharmaceutical industry.
Collaborations:
Shum's collaborative spirit is evident in his work with esteemed colleagues such as Yong Mi Choi-Sledeski and Nakyen Choy, who have supported his endeavors and shared in his success.
Conclusion:
In conclusion, Patrick Wai-Kwok Shum's exemplary career path, marked by a dedication to innovation and the development of pioneering inventions, solidifies his position as a respected inventor in the industry. His work at Sanofi and collaborations with talented professionals underscore his commitment to driving technological advancements and shaping the future of the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
